137 related articles for article (PubMed ID: 26678856)
1. γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP).
Lessard CB; Cottrell BA; Maruyama H; Suresh S; Golde TE; Koo EH
PLoS One; 2015; 10(12):e0144758. PubMed ID: 26678856
[TBL] [Abstract][Full Text] [Related]
2. An NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1.
Sala Frigerio C; Kukar TL; Fauq A; Engel PC; Golde TE; Walsh DM
Biochemistry; 2009 Nov; 48(46):10894-904. PubMed ID: 19821615
[TBL] [Abstract][Full Text] [Related]
3. Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region.
Kukar TL; Ladd TB; Robertson P; Pintchovski SA; Moore B; Bann MA; Ren Z; Jansen-West K; Malphrus K; Eggert S; Maruyama H; Cottrell BA; Das P; Basi GS; Koo EH; Golde TE
J Biol Chem; 2011 Nov; 286(46):39804-12. PubMed ID: 21868378
[TBL] [Abstract][Full Text] [Related]
4. Independent relationship between amyloid precursor protein (APP) dimerization and γ-secretase processivity.
Jung JI; Premraj S; Cruz PE; Ladd TB; Kwak Y; Koo EH; Felsenstein KM; Golde TE; Ran Y
PLoS One; 2014; 9(10):e111553. PubMed ID: 25350374
[TBL] [Abstract][Full Text] [Related]
5. Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.
Kim M; Bezprozvanny I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948396
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.
Quintero-Monzon O; Martin MM; Fernandez MA; Cappello CA; Krzysiak AJ; Osenkowski P; Wolfe MS
Biochemistry; 2011 Oct; 50(42):9023-35. PubMed ID: 21919498
[TBL] [Abstract][Full Text] [Related]
7. Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction.
Hata S; Fujishige S; Araki Y; Kato N; Araseki M; Nishimura M; Hartmann D; Saftig P; Fahrenholz F; Taniguchi M; Urakami K; Akatsu H; Martins RN; Yamamoto K; Maeda M; Yamamoto T; Nakaya T; Gandy S; Suzuki T
J Biol Chem; 2009 Dec; 284(52):36024-36033. PubMed ID: 19864413
[TBL] [Abstract][Full Text] [Related]
8. Increased H-Bond Stability Relates to Altered ε-Cleavage Efficiency and Aβ Levels in the I45T Familial Alzheimer's Disease Mutant of APP.
Götz A; Högel P; Silber M; Chaitoglou I; Luy B; Muhle-Goll C; Scharnagl C; Langosch D
Sci Rep; 2019 Mar; 9(1):5321. PubMed ID: 30926830
[TBL] [Abstract][Full Text] [Related]
9. The Large Ectodomain of APP Prevents APP from being Directly Cleaved by γ-Secretase.
Li Y; Li H; Liang W; Li Y; Wang Z
Front Biosci (Landmark Ed); 2024 Feb; 29(2):78. PubMed ID: 38420818
[TBL] [Abstract][Full Text] [Related]
10. Steroids as γ-secretase modulators.
Jung JI; Ladd TB; Kukar T; Price AR; Moore BD; Koo EH; Golde TE; Felsenstein KM
FASEB J; 2013 Sep; 27(9):3775-85. PubMed ID: 23716494
[TBL] [Abstract][Full Text] [Related]
11. Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species.
Wagner SL; Zhang C; Cheng S; Nguyen P; Zhang X; Rynearson KD; Wang R; Li Y; Sisodia SS; Mobley WC; Tanzi RE
Biochemistry; 2014 Feb; 53(4):702-13. PubMed ID: 24401146
[TBL] [Abstract][Full Text] [Related]
12. γ-Secretase inhibitors and modulators.
Golde TE; Koo EH; Felsenstein KM; Osborne BA; Miele L
Biochim Biophys Acta; 2013 Dec; 1828(12):2898-907. PubMed ID: 23791707
[TBL] [Abstract][Full Text] [Related]
13. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
Weissmiller AM; Natera-Naranjo O; Reyna SM; Pearn ML; Zhao X; Nguyen P; Cheng S; Goldstein LS; Tanzi RE; Wagner SL; Mobley WC; Wu C
PLoS One; 2015; 10(2):e0118379. PubMed ID: 25710492
[TBL] [Abstract][Full Text] [Related]
14. How Modulator Binding at the Amyloidβ-γ-Secretase Interface Enhances Substrate Binding and Attenuates Membrane Distortion.
Chen SY; Koch M; Chávez-Gutiérrez L; Zacharias M
J Med Chem; 2023 Dec; 66(24):16772-16782. PubMed ID: 38059872
[TBL] [Abstract][Full Text] [Related]
15. Perturbations of the straight transmembrane α-helical structure of the amyloid precursor protein affect its processing by γ-secretase.
Lemmin T; Dimitrov M; Fraering PC; Dal Peraro M
J Biol Chem; 2014 Mar; 289(10):6763-6774. PubMed ID: 24469457
[TBL] [Abstract][Full Text] [Related]
16. Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.
Munter LM; Botev A; Richter L; Hildebrand PW; Althoff V; Weise C; Kaden D; Multhaup G
J Biol Chem; 2010 Jul; 285(28):21636-43. PubMed ID: 20452985
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Activation of γ-Secretase for Cleavage of the Notch1 Substrate.
Do HN; Malvankar SR; Wolfe MS; Miao Y
ACS Chem Neurosci; 2023 Dec; 14(23):4216-4226. PubMed ID: 37942767
[TBL] [Abstract][Full Text] [Related]
18. Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage.
Ho A; Südhof TC
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2548-53. PubMed ID: 14983046
[TBL] [Abstract][Full Text] [Related]
19. APH1 polar transmembrane residues regulate the assembly and activity of presenilin complexes.
Pardossi-Piquard R; Yang SP; Kanemoto S; Gu Y; Chen F; Böhm C; Sevalle J; Li T; Wong PC; Checler F; Schmitt-Ulms G; St George-Hyslop P; Fraser PE
J Biol Chem; 2009 Jun; 284(24):16298-16307. PubMed ID: 19369254
[TBL] [Abstract][Full Text] [Related]
20. Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides.
Hanbouch L; Schaack B; Kasri A; Fontaine G; Gkanatsiou E; Brinkmalm G; Camporesi E; Portelius E; Blennow K; Mourier G; Gilles N; Millan MJ; Marquer C; Zetterberg H; Boussicault L; Potier MC
Mol Neurobiol; 2022 Nov; 59(11):7056-7073. PubMed ID: 36076005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
